Sapir Venture Partners

Founded in 2015, Sapir Venture Partners is a venture capital firm based in Jerusalem, Israel. It focuses on pre-seed stage investments in biotech and deep-technology sectors, providing mentorship to founders leveraging cutting-edge science for positive impact.

Gil Fuchsberg

Venture Partner

Brynne Stanton

Venture Partner

Yossi Tsuria

Venture Partner

20 past transactions

Lidwave

Seed Round in 2024
Lidwave is a developer of advanced 3D sensing solutions aimed at transforming industries reliant on LiDAR technology. By introducing a novel three-dimensional sensing architecture, the company addresses significant limitations in traditional LiDAR and radar systems, particularly concerning bandwidth constraints. Its innovative Finite Coherence Ranging (FCR) technology delivers enhanced four-dimensional sensing capabilities, enabling precise Doppler and depth information. This breakthrough allows businesses to enhance automation across various sectors, including autonomous vehicles, industrial robotics, and smart cities, ultimately facilitating smarter and safer decision-making. Lidwave's approach not only resolves the challenges associated with existing sensing methods but also positions it as a leader in disruptive sensing technology.

Enzymit

Series A in 2024
Enzymit is a biotechnology company focused on revolutionizing global manufacturing through sustainable and efficient bio-production methods. It specializes in developing cell-free bio-production technology that aims to eliminate the inefficiencies and complexities associated with traditional bio-production. Enzymit employs artificial intelligence and deep learning algorithms to design novel enzymes, which serve as molecular machines capable of transforming abundant feedstocks into valuable products, including pharmaceuticals, cosmetics, food, and materials. The company’s small, modular bio-reactors facilitate this process, promoting resource independence while minimizing environmental impact. By moving away from conventional whole-cell methods to utilizing nature's elemental building blocks, Enzymit enhances cost-effectiveness, efficiency, and sustainability in bio-production, while also providing greater flexibility in product customization for various industries.

Enzymit

Seed Round in 2022
Enzymit is a biotechnology company focused on revolutionizing global manufacturing through sustainable and efficient bio-production methods. It specializes in developing cell-free bio-production technology that aims to eliminate the inefficiencies and complexities associated with traditional bio-production. Enzymit employs artificial intelligence and deep learning algorithms to design novel enzymes, which serve as molecular machines capable of transforming abundant feedstocks into valuable products, including pharmaceuticals, cosmetics, food, and materials. The company’s small, modular bio-reactors facilitate this process, promoting resource independence while minimizing environmental impact. By moving away from conventional whole-cell methods to utilizing nature's elemental building blocks, Enzymit enhances cost-effectiveness, efficiency, and sustainability in bio-production, while also providing greater flexibility in product customization for various industries.

DeepCure

Series A in 2021
DeepCure Inc. is a biotechnology company based in Boston, Massachusetts, specializing in artificial intelligence-driven drug discovery. Founded in 2018, DeepCure develops innovative solutions for small-molecule drug development, utilizing advanced deep learning algorithms and a proprietary database of chemical compounds. The company offers services such as De-novo Lead Discovery, which employs AI algorithms to assess potential drug candidates from a virtual library, and Artificial Intelligence-driven Lead Optimization, aimed at enhancing drug development processes. Additionally, DeepCure's platform includes a molecular database designed to maximize the diversity and synthesizability of chemical compounds. By integrating AI predictive modeling and a feedback loop, DeepCure focuses on creating effective therapeutics for unmet medical needs, ultimately aiming to expedite the development of novel precision medicines.

NeuroKaire

Series A in 2021
NeuroKaire develops personalized psychiatry testing tools. It uses innovative technology to predict the most effective drug treatment for patients, enabling faster recovery, fewer side effects, and lower dosing.

Miter

Pre Seed Round in 2021
Miter is set out to fix bad meetings. The company provides its users with a specific, outcome-oriented, shared goal and a simple list of topics for meetings. Milter aims to help motivated people improve their meetings and make better use of their teams' time and energy.

Fabric

Seed Round in 2021
OUR MISSION Fabric is on a mission to create a world where everyone belongs, one in-person interaction at a time. We do this by augmenting shared experiences, starting with the number one industry that brings people together: Sports. OUR TEAM Fabric’s team is a diverse group of technologists, entrepreneurs, humanists, executives, mathematicians, and designers who are devoted to creating a world where everyone belongs through the creation of the world’s most accessible and innovative technology platform. OUR PLATFORM Fabric is a venture-backed geospatial web3 platform for sports teams and leagues. Our platform transforms the fan experience by delivering immersive real-time AR, blockchain, social, and gaming experiences, powered by no-code tools and an AI engine that understands the team’s needs. Fabric Spaces transform smartphones into an interactive and social 3D jumbotron in every fan's pocket, unlocking a new layer of the in-stadium experience. Fabric transports fans to the unlimited possibilities that come from the blending of physical and digital worlds all under the official banner of their favorite team. We call this the Reality-First Metaverse™, where fans join the team.

Diptera.ai

Seed Round in 2021
Diptera.ai develops mosquito control technology that uses the sterile insect technique to reduce mosquito populations. It offers a ready-to-use module that releases sterile male mosquitoes over a period of weeks, enabling ongoing suppression without on-site rearing or sorting facilities. The system combines advanced optics, computer vision, and artificial intelligence to prepare and deploy sterile insects, allowing municipal authorities to conduct large-scale vector control more affordably and efficiently. Based in Jerusalem, Israel, the company aims to make sterile insect technique accessible for urban pest management by eliminating the need for traditional rearing infrastructure and simplifying deployment. The solution is designed to be integrated into existing public health programs to curb disease-carrying mosquitoes while reducing operational complexity.

Enzymit

Pre Seed Round in 2020
Enzymit is a biotechnology company focused on revolutionizing global manufacturing through sustainable and efficient bio-production methods. It specializes in developing cell-free bio-production technology that aims to eliminate the inefficiencies and complexities associated with traditional bio-production. Enzymit employs artificial intelligence and deep learning algorithms to design novel enzymes, which serve as molecular machines capable of transforming abundant feedstocks into valuable products, including pharmaceuticals, cosmetics, food, and materials. The company’s small, modular bio-reactors facilitate this process, promoting resource independence while minimizing environmental impact. By moving away from conventional whole-cell methods to utilizing nature's elemental building blocks, Enzymit enhances cost-effectiveness, efficiency, and sustainability in bio-production, while also providing greater flexibility in product customization for various industries.

Gabriel

Seed Round in 2020
Gabriel is a safety technology company that builds an integrated network of smart sensors and software to improve threat detection and crisis management. The system is designed for easy installation and affordability, with a primary focus on schools and public buildings. It delivers instant alerts and critical communication tools to support survival and preparedness during emergencies, enabling rapid response and coordination while reducing overall costs compared with existing solutions.

Strattic

Seed Round in 2019
Strattic Ltd. is a technology company based in Jerusalem, Israel, founded in 2016. It specializes in providing a hosted website security and optimization platform that focuses on converting CMS-based websites, particularly those built on WordPress, into static versions. This transformation enhances website performance by making them faster, more scalable, and significantly more secure, effectively reducing vulnerabilities associated with dynamic sites. Strattic's platform operates on a serverless architecture, allowing site owners to manage their WordPress content seamlessly while the dynamic aspects are isolated behind authentication measures. With a simple one-click deployment, site owners can publish their websites as static sites, which consist of HTML, CSS, and JavaScript, ensuring a secure online presence without compromising functionality or ease of use.

NeuroKaire

Seed Round in 2019
NeuroKaire develops personalized psychiatry testing tools. It uses innovative technology to predict the most effective drug treatment for patients, enabling faster recovery, fewer side effects, and lower dosing.

CaliberMind

Seed Round in 2019
CaliberMind provides a B2B customer data platform for revenue marketers that integrates data, enables marketing attribution, engagement scoring, funnel insights, and churn analysis to optimize sales and marketing outcomes. Positioned as a buyer intelligence solution, the platform helps organizations leverage their sales, marketing, and customer data to improve productivity, engagement, and revenue through features such as account engagement, chain-based attribution, and marketing workflow automation, and by linking data across touchpoints to inform pipeline decisions and identify churn risk.

Lance

Pre Seed Round in 2019
Lance, established in 2017 and based in New York, specializes in providing expense management and tax prediction software tailored to freelancers. Its platform offers integrated services including financing, legal, and taxation assistance, enabling freelancers to consolidate and monitor invoices, payments, and accounts. Lance's software also streamlines expense organization and maximizes deductions, while facilitating business registration for freelancers.

Goodlight

Pre Seed Round in 2019
Goodlight is a risk analytics platform that focuses on identifying potential issues within an organization's workforce. The company employs digital technology and machine learning to analyze and assess employee risk profiles after hiring. By monitoring various data sources for abnormalities, Goodlight's platform alerts clients to early signs of employee risk, allowing organizations to proactively address these issues. This capability enables clients to mitigate workforce risks effectively and reduce the costs associated with incidents within their organizations.

DeepCure

Pre Seed Round in 2018
DeepCure Inc. is a biotechnology company based in Boston, Massachusetts, specializing in artificial intelligence-driven drug discovery. Founded in 2018, DeepCure develops innovative solutions for small-molecule drug development, utilizing advanced deep learning algorithms and a proprietary database of chemical compounds. The company offers services such as De-novo Lead Discovery, which employs AI algorithms to assess potential drug candidates from a virtual library, and Artificial Intelligence-driven Lead Optimization, aimed at enhancing drug development processes. Additionally, DeepCure's platform includes a molecular database designed to maximize the diversity and synthesizability of chemical compounds. By integrating AI predictive modeling and a feedback loop, DeepCure focuses on creating effective therapeutics for unmet medical needs, ultimately aiming to expedite the development of novel precision medicines.

SynVaccine

Seed Round in 2018
SynVaccine develops preventive vaccines against major human pathogens. It holds licenses for technologies enabling computational design of viral genomes and physical DNA editing of vaccine libraries.

NeuroKaire

Pre Seed Round in 2018
NeuroKaire develops personalized psychiatry testing tools. It uses innovative technology to predict the most effective drug treatment for patients, enabling faster recovery, fewer side effects, and lower dosing.

ConsortiaTX

Pre Seed Round in 2018
ConsortiaTX, Inc. is a seed stage, pre-clinical bio-therapeutics company that emerged from research laboratories at Brigham & Women’s Hospital and Children’s Hospital in Boston. The company’s intellectual property around food allergies and the human gut microbiome is based on the work of Lynn Bry, M.D., Ph.D., Georg Gerber, M.D., Ph.D. (both at BWH), and Talal Chatilla, Ph.D. (at CHB) and others.

PlanetWatchers

Seed Round in 2017
PlanetWatchers is a geospatial analytics company that provides a cloud-based platform to monitor and manage natural assets across multiple sectors, including forestry, energy, government, and agriculture. The software integrates machine learning, elastic cloud infrastructure, and multiple satellite sources to deliver automated monitoring, alerting, and reporting on large-scale assets at regional and global scales. It enables enterprises, governments and NGOs to track asset conditions, assess risks, and improve operational efficiency. In the crop insurance domain, the platform supports policy data capture and claims validation, delivering precise acreage reporting and damage analysis to support underwriting and customer service. Headquartered in San Francisco, PlanetWatchers focuses on turning satellite-derived insights into actionable information for asset management, environmental monitoring, and policy-driven applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.